Best Agrolife Limited announced its financial results for the third quarter and nine months ended December 31, 2025. The company reported revenue from operations of ₹202.9 crore in Q3 FY26, a decrease from ₹274.1 crore in Q3 FY25, attributed to erratic rainfall and market factors. The gross margin for the quarter was ₹65 crore, down from ₹89.0 crore year-on-year. EBITDA for the quarter was ₹3.8 crore, an improvement from a loss of ₹5.8 crore in Q3 FY25, with the EBITDA margin at 1.9%. The company reported a PAT loss of ₹12.7 crore, an improvement from a loss of ₹24.2 crore in the corresponding quarter last year. For the nine months ended December 31, 2025, revenue from operations stood at ₹1,101.1 crore, compared to ₹1,540 crore in the same period last year. Gross margin for 9M FY26 was ₹345.2 crore, down from ₹468.4 crore in 9M FY25. EBITDA for 9M FY26 was ₹127.1 crore, compared to ₹195.9 crore in 9M FY25, with an EBITDA margin of 11.5%. The company reported a PAT of ₹46.1 crore for 9M FY26, compared to ₹91.8 crore in 9M FY25. Mr. Vimal Kumar, Managing Director, stated that the sales performance was impacted by exceptionally high rainfall in October 2025, disruptions in cropping cycles, and lower pest incidences. He also noted that declining crop and horticulture prices compressed farm incomes, and elevated generic inventory led to increased price competition. Despite these challenges, two newly launched patented combinations, BestMan and Fetagen, achieved over four lakh treated acres each in their first year. The company is focused on cost optimization and inventory rationalization, strengthening its balance sheet. Looking ahead, Best Agrolife plans to launch three additional patented combinations in the next 3-9 months.
